Dr. Monjazeb is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4501 X Street, G120
Uc Davis Health System Department Of Radiation Oncology
Sacramento, CA 95817Phone+1 336-575-2977
Education & Training
- Wake Forest University Baptist Medical CenterResidency, Radiation Oncology, 2006 - 2010
- Los Angeles County-Harbor-UCLA Medical CenterInternship, Transitional Year, 2005 - 2006
- Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2005
Certifications & Licensure
- CA State Medical License 2010 - 2025
- NC State Medical License 2006 - 2010
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Start of enrollment: 2014 Jul 11
- UCDCC#271: Phase I/II Trial of Epacadostat, Intralesional SD101, Radiotherapy in Patients With Lymphoma Start of enrollment: 2018 Jan 17
- UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade Start of enrollment: 2019 May 20
Publications & Presentations
PubMed
- 110 citationsDurvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(...Jonathan D Schoenfeld, Anita Giobbie-Hurder, Srinika Ranasinghe, Katrina Z Kao, Ana Lako
The Lancet. Oncology. 2022-02-01 - 34 citationsImmunoediting and Antigen Loss: Overcoming the Achilles Heel of Immunotherapy with Antigen Non-Specific TherapiesArta M. Monjazeb, Anthony E. Zamora, Steven K. Grossenbacher, Annie Mirsoian, Gail D. Sckisel
Frontiers in Oncology. 2013-07-26 - 58 citationsEnhanced targeting of stem-like solid tumor cells with radiation and natural killer cells.Erik Ames, Robert J. Canter, Steven K. Grossenbacher, Stephanie Mac, Rachel C. Smith
Oncoimmunology. 2015-06-05
Journal Articles
- PD-1 Blockade Reverses Obesity-Mediated T Cell Priming ImpairmentArta Monjazeb, MD, Frontiers in Immunology
- Paradoxical Effects of Obesity on T Cell Function During Tumor Progression and PD-1 Checkpoint BlockadeR Rivkah Isseroff, Emanual Maverakis, Robert J Canter, Kurt A Schalper, Karen Kelly, Bruce R Blazar, Catherine T Le, Dan L Longo, Arta M Monjazeb, Sami Ibrahimi, Nature
- The Challenge for Development of Valuable Immuno-Oncology BiomarkersArta M Monjazeb, Janice M Mehnert, Lyndsay N Harris, Clinical Cancer Research
- Join now to see all
Press Mentions
- How Does Obesity Affect Immunity, Cancer and Radiotherapy? It’s Complicated!January 26th, 2023
- Colon and Rectal Cancer on the Rise in Young AdultsMarch 9th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: